DBV TECHNOLOGIES |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.212 EUR | +0.83% |
|
+1.34% | -34.45% |
| May. 10 | European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3% | MT |
| May. 09 | China confirms its awakening |  |
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Sector
Pharmaceuticals
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
1.212
EUR
Average target price
6.5
EUR
Spread / Average Target
+436.30%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -34.45% | 126M | |
| +7.91% | 72.81B | |
| +12.64% | 9.13B | |
| -10.56% | 5.13B | |
| +58.79% | 4.99B | |
| +4.07% | 3.9B | |
| -16.90% | 2.48B | |
| -26.13% | 2.32B | |
| +19.31% | 2.17B | |
| -0.50% | 1.64B |
- Stock Market
- Equities
- DBV Stock
- Funds and ETFs DBV Technologies
